Skip to main content
Erschienen in: Documenta Ophthalmologica 1/2015

01.08.2015 | Original Research Article

Vigabatrin can enhance electroretinographic responses in pigmented and albino rats

verfasst von: James D. Akula, Emily R. Noonan, Alessia Di Nardo, Tara L. Favazza, Nan Zhang, Mustafa Sahin, Ronald M. Hansen, Anne B. Fulton

Erschienen in: Documenta Ophthalmologica | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate the effects of the antiepileptic medication vigabatrin (VGB) on the retina of pigmented rats.

Methods

Scotopic and photopic electroretinograms were recorded from dark- and light-adapted Long-Evans (pigmented) and Sprague Dawley (albino) rats administered, daily, 52–55 injections of 250 mg·kg−1·day−1 VGB or 25–26 injections of 500 mg·kg−1·day−1 VGB, or a corresponding number of sham injections. Sensitivity and saturated amplitude of the rod photoresponse (S, Rm P3) and postreceptor response (1/σ, Vm) were derived, as were sensitivity and amplitude of the cone-mediated postreceptor response (1/σ cone, Vm cone). The oscillatory potentials and responses to a series of flickering lights (6.25, 12.5, 25 and 50 Hz) were studied in the time and frequency domains. A subset of rats’ eyes was harvested for Western blotting or histology.

Results

Of the parameters derived from dark-adapted ERG responses, in both pigmented and albino rats, VGB repeatedly and reliably enhanced electroretinographic parameters; no significant ERG deficits were noted. No significant alterations were observed in ER/oxidative stress or in the Akt cell death/survival pathway. There were migrations of photoreceptor nuclei toward the RPE and outgrowths of bipolar cell dendrites into the outer nuclear layer in VGB-treated rats; these were never observed in sham-treated animals.

Conclusions

Although VGB is associated with retinal dysfunction in patients and VGB toxicity has been demonstrated by other laboratories in the albino rat, in our pigmented and albino rats, VGB did not induce deficits in, but rather enhanced, retinal function. Nonetheless, retinal neuronal dysplasia was observed.
Literatur
1.
Zurück zum Zitat Rogawski MA, Loscher W (2004) The neurobiology of antiepileptic drugs. Nat Rev Neurosci 5:553–564PubMedCrossRef Rogawski MA, Loscher W (2004) The neurobiology of antiepileptic drugs. Nat Rev Neurosci 5:553–564PubMedCrossRef
2.
Zurück zum Zitat Maguire MJ, Hemming K, Wild JM, Hutton JL, Marson AG (2010) Prevalence of visual field loss following exposure to vigabatrin therapy: a systematic review. Epilepsia 51:2423–2431PubMedCrossRef Maguire MJ, Hemming K, Wild JM, Hutton JL, Marson AG (2010) Prevalence of visual field loss following exposure to vigabatrin therapy: a systematic review. Epilepsia 51:2423–2431PubMedCrossRef
3.
Zurück zum Zitat Harding GF, Robertson K, Spencer EL, Holliday I (2002) Vigabatrin; its effect on the electrophysiology of vision. Doc Ophthalmol 104:213–229PubMedCrossRef Harding GF, Robertson K, Spencer EL, Holliday I (2002) Vigabatrin; its effect on the electrophysiology of vision. Doc Ophthalmol 104:213–229PubMedCrossRef
4.
Zurück zum Zitat Buncic JR, Westall CA, Panton CM, Munn JR, MacKeen LD, Logan WJ (2004) Characteristic retinal atrophy with secondary “inverse” optic atrophy identifies vigabatrin toxicity in children. Ophthalmology 111:1935–1942PubMedCrossRef Buncic JR, Westall CA, Panton CM, Munn JR, MacKeen LD, Logan WJ (2004) Characteristic retinal atrophy with secondary “inverse” optic atrophy identifies vigabatrin toxicity in children. Ophthalmology 111:1935–1942PubMedCrossRef
5.
Zurück zum Zitat Westall CA, Wright T, Cortese F, Kumarappah A, Snead OC 3rd, Buncic JR (2014) Vigabatrin retinal toxicity in children with infantile spasms: an observational cohort study. Neurology 83:2262–2268PubMedCentralPubMedCrossRef Westall CA, Wright T, Cortese F, Kumarappah A, Snead OC 3rd, Buncic JR (2014) Vigabatrin retinal toxicity in children with infantile spasms: an observational cohort study. Neurology 83:2262–2268PubMedCentralPubMedCrossRef
6.
Zurück zum Zitat Westall CA, Logan WJ, Smith K, Buncic JR, Panton CM, Abdolell M (2002) The Hospital for Sick Children, Toronto, Longitudinal ERG study of children on vigabatrin. Doc Ophthalmol 104:133–149PubMedCentralPubMedCrossRef Westall CA, Logan WJ, Smith K, Buncic JR, Panton CM, Abdolell M (2002) The Hospital for Sick Children, Toronto, Longitudinal ERG study of children on vigabatrin. Doc Ophthalmol 104:133–149PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat Moskowitz A, Hansen RM, Eklund SE, Fulton AB (2012) Electroretinographic (ERG) responses in pediatric patients using vigabatrin. Doc Ophthalmol 124:197–209PubMedCrossRef Moskowitz A, Hansen RM, Eklund SE, Fulton AB (2012) Electroretinographic (ERG) responses in pediatric patients using vigabatrin. Doc Ophthalmol 124:197–209PubMedCrossRef
8.
Zurück zum Zitat Morong S, Westall CA, Nobile R, Buncic JR, Logan WJ, Panton CM, Abdolell M (2003) Longitudinal changes in photopic OPs occurring with vigabatrin treatment. Doc Ophthalmol 107:289–297PubMedCentralPubMedCrossRef Morong S, Westall CA, Nobile R, Buncic JR, Logan WJ, Panton CM, Abdolell M (2003) Longitudinal changes in photopic OPs occurring with vigabatrin treatment. Doc Ophthalmol 107:289–297PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat McCoy B, Wright T, Weiss S, Go C, Westall CA (2011) Electroretinogram changes in a pediatric population with epilepsy: is vigabatrin acting alone? J Child Neurol 26:729–733PubMedCrossRef McCoy B, Wright T, Weiss S, Go C, Westall CA (2011) Electroretinogram changes in a pediatric population with epilepsy: is vigabatrin acting alone? J Child Neurol 26:729–733PubMedCrossRef
10.
Zurück zum Zitat Dragas R, Westall C, Wright T (2014) Changes in the ERG d-wave with vigabatrin treatment in a pediatric cohort. Doc Ophthalmol 129:97–104PubMedCrossRef Dragas R, Westall C, Wright T (2014) Changes in the ERG d-wave with vigabatrin treatment in a pediatric cohort. Doc Ophthalmol 129:97–104PubMedCrossRef
11.
Zurück zum Zitat Sergott RC, Wheless JW, Smith MC, Westall CA, Kardon RH, Arnold A, Foroozan R, Sagar SM (2010) Evidence-based review of recommendations for visual function testing in patients treated with vigabatrin. Neuro-Ophthalmology 34:20–35CrossRef Sergott RC, Wheless JW, Smith MC, Westall CA, Kardon RH, Arnold A, Foroozan R, Sagar SM (2010) Evidence-based review of recommendations for visual function testing in patients treated with vigabatrin. Neuro-Ophthalmology 34:20–35CrossRef
12.
Zurück zum Zitat Sieving PA (1993) Photopic ON- and OFF-pathway abnormalities in retinal dystrophies. Trans Am Ophthalmol Soc 91:701–773PubMedCentralPubMed Sieving PA (1993) Photopic ON- and OFF-pathway abnormalities in retinal dystrophies. Trans Am Ophthalmol Soc 91:701–773PubMedCentralPubMed
13.
Zurück zum Zitat Ueno S, Kondo M, Niwa Y, Terasaki H, Miyake Y (2004) Luminance dependence of neural components that underlies the primate photopic electroretinogram. Invest Ophthalmol Vis Sci 45:1033–1040PubMedCrossRef Ueno S, Kondo M, Niwa Y, Terasaki H, Miyake Y (2004) Luminance dependence of neural components that underlies the primate photopic electroretinogram. Invest Ophthalmol Vis Sci 45:1033–1040PubMedCrossRef
14.
Zurück zum Zitat Duboc A, Hanoteau N, Simonutti M, Rudolf G, Nehlig A, Sahel JA, Picaud S (2004) Vigabatrin, the GABA-transaminase inhibitor, damages cone photoreceptors in rats. Ann Neurol 55:695–705PubMedCrossRef Duboc A, Hanoteau N, Simonutti M, Rudolf G, Nehlig A, Sahel JA, Picaud S (2004) Vigabatrin, the GABA-transaminase inhibitor, damages cone photoreceptors in rats. Ann Neurol 55:695–705PubMedCrossRef
15.
Zurück zum Zitat Wang QP, Jammoul F, Duboc A, Gong J, Simonutti M, Dubus E, Craft CM, Ye W, Sahel JA, Picaud S (2008) Treatment of epilepsy: the GABA-transaminase inhibitor, vigabatrin, induces neuronal plasticity in the mouse retina. Eur J Neurosci 27:2177–2187PubMedCentralPubMedCrossRef Wang QP, Jammoul F, Duboc A, Gong J, Simonutti M, Dubus E, Craft CM, Ye W, Sahel JA, Picaud S (2008) Treatment of epilepsy: the GABA-transaminase inhibitor, vigabatrin, induces neuronal plasticity in the mouse retina. Eur J Neurosci 27:2177–2187PubMedCentralPubMedCrossRef
16.
Zurück zum Zitat Jammoul F, Wang Q, Nabbout R, Coriat C, Duboc A, Simonutti M, Dubus E, Craft CM, Ye W, Collins SD, Dulac O, Chiron C, Sahel JA, Picaud S (2009) Taurine deficiency is a cause of vigabatrin-induced retinal phototoxicity. Ann Neurol 65:98–107PubMedCentralPubMedCrossRef Jammoul F, Wang Q, Nabbout R, Coriat C, Duboc A, Simonutti M, Dubus E, Craft CM, Ye W, Collins SD, Dulac O, Chiron C, Sahel JA, Picaud S (2009) Taurine deficiency is a cause of vigabatrin-induced retinal phototoxicity. Ann Neurol 65:98–107PubMedCentralPubMedCrossRef
17.
Zurück zum Zitat Jammoul F, Degardin J, Pain D, Gondouin P, Simonutti M, Dubus E, Caplette R, Fouquet S, Craft CM, Sahel JA, Picaud S (2010) Taurine deficiency damages photoreceptors and retinal ganglion cells in vigabatrin-treated neonatal rats. Mol Cell Neurosci 43:414–421PubMedCentralPubMedCrossRef Jammoul F, Degardin J, Pain D, Gondouin P, Simonutti M, Dubus E, Caplette R, Fouquet S, Craft CM, Sahel JA, Picaud S (2010) Taurine deficiency damages photoreceptors and retinal ganglion cells in vigabatrin-treated neonatal rats. Mol Cell Neurosci 43:414–421PubMedCentralPubMedCrossRef
18.
Zurück zum Zitat Gaucher D, Arnault E, Husson Z, Froger N, Dubus E, Gondouin P, Dherbecourt D, Degardin J, Simonutti M, Fouquet S, Benahmed MA, Elbayed K, Namer IJ, Massin P, Sahel JA, Picaud S (2012) Taurine deficiency damages retinal neurones: cone photoreceptors and retinal ganglion cells. Amino Acids 43:1979–1993PubMedCentralPubMedCrossRef Gaucher D, Arnault E, Husson Z, Froger N, Dubus E, Gondouin P, Dherbecourt D, Degardin J, Simonutti M, Fouquet S, Benahmed MA, Elbayed K, Namer IJ, Massin P, Sahel JA, Picaud S (2012) Taurine deficiency damages retinal neurones: cone photoreceptors and retinal ganglion cells. Amino Acids 43:1979–1993PubMedCentralPubMedCrossRef
19.
Zurück zum Zitat Ponjavic V, Granse L, Kjellstrom S, Andreasson S, Bruun A (2004) Alterations in electroretinograms and retinal morphology in rabbits treated with vigabatrin. Doc Ophthalmol 108:125–133PubMedCrossRef Ponjavic V, Granse L, Kjellstrom S, Andreasson S, Bruun A (2004) Alterations in electroretinograms and retinal morphology in rabbits treated with vigabatrin. Doc Ophthalmol 108:125–133PubMedCrossRef
20.
Zurück zum Zitat Kjellstrom U, Kjellstrom S, Bruun A, Andreasson S, Ponjavic V (2006) Retinal function in rabbits does not improve 4-5 months after terminating treatment with vigabatrin. Doc Ophthalmol 112:35–41PubMedCrossRef Kjellstrom U, Kjellstrom S, Bruun A, Andreasson S, Ponjavic V (2006) Retinal function in rabbits does not improve 4-5 months after terminating treatment with vigabatrin. Doc Ophthalmol 112:35–41PubMedCrossRef
21.
Zurück zum Zitat Kjellstrom U, Bruun A, Ghosh F, Andreasson S, Ponjavic V (2009) Dose-related changes in retinal function and PKC-alpha expression in rabbits on vigabatrin medication. Effect of vigabatrin in the rabbit eye. Graefe’s Arch Clin Exp Ophthalmol = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 247:1057–1067CrossRef Kjellstrom U, Bruun A, Ghosh F, Andreasson S, Ponjavic V (2009) Dose-related changes in retinal function and PKC-alpha expression in rabbits on vigabatrin medication. Effect of vigabatrin in the rabbit eye. Graefe’s Arch Clin Exp Ophthalmol = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 247:1057–1067CrossRef
22.
Zurück zum Zitat Izumi Y, Ishikawa M, Benz AM, Izumi M, Zorumski CF, Thio LL (2004) Acute vigabatrin retinotoxicity in albino rats depends on light but not GABA. Epilepsia 45:1043–1048PubMedCrossRef Izumi Y, Ishikawa M, Benz AM, Izumi M, Zorumski CF, Thio LL (2004) Acute vigabatrin retinotoxicity in albino rats depends on light but not GABA. Epilepsia 45:1043–1048PubMedCrossRef
23.
Zurück zum Zitat Heim MK, Gidal BE (2012) Vigabatrin-associated retinal damage: potential biochemical mechanisms. Acta Neurol Scand 126:219–228PubMedCrossRef Heim MK, Gidal BE (2012) Vigabatrin-associated retinal damage: potential biochemical mechanisms. Acta Neurol Scand 126:219–228PubMedCrossRef
24.
Zurück zum Zitat Akula JD, Hansen RM, Tzekov R, Favazza TL, Vyhovsky TC, Benador IY, Mocko JA, McGee D, Kubota R, Fulton AB (2010) Visual cycle modulation in neurovascular retinopathy. Exp Eye Res 91:153–161PubMedCrossRef Akula JD, Hansen RM, Tzekov R, Favazza TL, Vyhovsky TC, Benador IY, Mocko JA, McGee D, Kubota R, Fulton AB (2010) Visual cycle modulation in neurovascular retinopathy. Exp Eye Res 91:153–161PubMedCrossRef
25.
Zurück zum Zitat Akula JD, Mocko JA, Benador IY, Hansen RM, Favazza TL, Vyhovsky TC, Fulton AB (2008) The neurovascular relation in oxygen-induced retinopathy. Mol Vis 14:2499–2508PubMedCentralPubMed Akula JD, Mocko JA, Benador IY, Hansen RM, Favazza TL, Vyhovsky TC, Fulton AB (2008) The neurovascular relation in oxygen-induced retinopathy. Mol Vis 14:2499–2508PubMedCentralPubMed
26.
Zurück zum Zitat Akula JD, Lyubarsky AL, Naarendorp F (2003) The sensitivity and spectral identity of the cones driving the b-wave of the rat electroretinogram. Vis Neurosci 20:109–117PubMedCrossRef Akula JD, Lyubarsky AL, Naarendorp F (2003) The sensitivity and spectral identity of the cones driving the b-wave of the rat electroretinogram. Vis Neurosci 20:109–117PubMedCrossRef
27.
Zurück zum Zitat Hood DC, Birch DG (1994) Rod phototransduction in retinitis pigmentosa: estimation and interpretation of parameters derived from the rod a-wave. Invest Ophthalmol Vis Sci 35:2948–2961PubMed Hood DC, Birch DG (1994) Rod phototransduction in retinitis pigmentosa: estimation and interpretation of parameters derived from the rod a-wave. Invest Ophthalmol Vis Sci 35:2948–2961PubMed
28.
Zurück zum Zitat Lamb TD, Pugh EN Jr (1992) A quantitative account of the activation steps involved in phototransduction in amphibian photoreceptors. J Physiol 449:719–758PubMedCentralPubMedCrossRef Lamb TD, Pugh EN Jr (1992) A quantitative account of the activation steps involved in phototransduction in amphibian photoreceptors. J Physiol 449:719–758PubMedCentralPubMedCrossRef
30.
Zurück zum Zitat Wurziger K, Lichtenberger T, Hanitzsch R (2001) On-bipolar cells and depolarising third-order neurons as the origin of the ERG-b-wave in the RCS rat. Vis Res 41:1091–1101PubMedCrossRef Wurziger K, Lichtenberger T, Hanitzsch R (2001) On-bipolar cells and depolarising third-order neurons as the origin of the ERG-b-wave in the RCS rat. Vis Res 41:1091–1101PubMedCrossRef
31.
Zurück zum Zitat Robson JG, Frishman LJ (1995) Response linearity and kinetics of the cat retina: the bipolar cell component of the dark-adapted electroretinogram. Vis Neurosci 12:837–850PubMedCrossRef Robson JG, Frishman LJ (1995) Response linearity and kinetics of the cat retina: the bipolar cell component of the dark-adapted electroretinogram. Vis Neurosci 12:837–850PubMedCrossRef
32.
Zurück zum Zitat Liu K, Akula JD, Hansen RM, Moskowitz A, Kleinman MS, Fulton AB (2006) Development of the electroretinographic oscillatory potentials in normal and ROP rats. Invest Ophthalmol Vis Sci 47:5447–5452PubMedCrossRef Liu K, Akula JD, Hansen RM, Moskowitz A, Kleinman MS, Fulton AB (2006) Development of the electroretinographic oscillatory potentials in normal and ROP rats. Invest Ophthalmol Vis Sci 47:5447–5452PubMedCrossRef
33.
Zurück zum Zitat Bui BV, Armitage JA, Vingrys AJ (2002) Extraction and modelling of oscillatory potentials. Doc Ophthalmol 104:17–36PubMedCrossRef Bui BV, Armitage JA, Vingrys AJ (2002) Extraction and modelling of oscillatory potentials. Doc Ophthalmol 104:17–36PubMedCrossRef
34.
Zurück zum Zitat Akula JD, Mocko JA, Moskowitz A, Hansen RM, Fulton AB (2007) The oscillatory potentials of the dark-adapted electroretinogram in retinopathy of prematurity. Invest Ophthalmol Vis Sci 48:5788–5797PubMedCentralPubMedCrossRef Akula JD, Mocko JA, Moskowitz A, Hansen RM, Fulton AB (2007) The oscillatory potentials of the dark-adapted electroretinogram in retinopathy of prematurity. Invest Ophthalmol Vis Sci 48:5788–5797PubMedCentralPubMedCrossRef
35.
Zurück zum Zitat Wachtmeister L (2001) Some aspects of the oscillatory response of the retina. Prog Brain Res 131:465–474PubMedCrossRef Wachtmeister L (2001) Some aspects of the oscillatory response of the retina. Prog Brain Res 131:465–474PubMedCrossRef
36.
Zurück zum Zitat Dong CJ, Agey P, Hare WA (2004) Origins of the electroretinogram oscillatory potentials in the rabbit retina. Vis Neurosci 21:533–543PubMedCrossRef Dong CJ, Agey P, Hare WA (2004) Origins of the electroretinogram oscillatory potentials in the rabbit retina. Vis Neurosci 21:533–543PubMedCrossRef
38.
Zurück zum Zitat Meikle L, Talos DM, Onda H, Pollizzi K, Rotenberg A, Sahin M, Jensen FE, Kwiatkowski DJ (2007) A mouse model of tuberous sclerosis: neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival. J Neurosci 27:5546–5558PubMedCrossRef Meikle L, Talos DM, Onda H, Pollizzi K, Rotenberg A, Sahin M, Jensen FE, Kwiatkowski DJ (2007) A mouse model of tuberous sclerosis: neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival. J Neurosci 27:5546–5558PubMedCrossRef
39.
Zurück zum Zitat Ron D, Walter P (2007) Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 8:519–529PubMedCrossRef Ron D, Walter P (2007) Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 8:519–529PubMedCrossRef
40.
Zurück zum Zitat Takahashi T, Morita K, Akagi R, Sassa S (2004) Heme oxygenase-1: a novel therapeutic target in oxidative tissue injuries. Curr Med Chem 11:1545–1561PubMedCrossRef Takahashi T, Morita K, Akagi R, Sassa S (2004) Heme oxygenase-1: a novel therapeutic target in oxidative tissue injuries. Curr Med Chem 11:1545–1561PubMedCrossRef
41.
Zurück zum Zitat Di Nardo A, Kramvis I, Cho N, Sadowski A, Meikle L, Kwiatkowski DJ, Sahin M (2009) Tuberous sclerosis complex activity is required to control neuronal stress responses in an mTOR-dependent manner. J Neurosci 29:5926–5937PubMedCentralPubMedCrossRef Di Nardo A, Kramvis I, Cho N, Sadowski A, Meikle L, Kwiatkowski DJ, Sahin M (2009) Tuberous sclerosis complex activity is required to control neuronal stress responses in an mTOR-dependent manner. J Neurosci 29:5926–5937PubMedCentralPubMedCrossRef
42.
Zurück zum Zitat Hood DC, Birch DG (2006) Measuring the health of the human photoreceptors with the leading edge of the a-wave. In: Heckenlively JR, Arden GB (eds) Principles and practice of clinical electrophysiology of vision, 2nd edn. MIT Press, Cambridge, Mass, pp 487–501 Hood DC, Birch DG (2006) Measuring the health of the human photoreceptors with the leading edge of the a-wave. In: Heckenlively JR, Arden GB (eds) Principles and practice of clinical electrophysiology of vision, 2nd edn. MIT Press, Cambridge, Mass, pp 487–501
43.
Zurück zum Zitat Robson JG, Frishman LJ (2014) The rod-driven a-wave of the dark-adapted mammalian electroretinogram. Prog Retin Eye Res 39:1–22PubMedCrossRef Robson JG, Frishman LJ (2014) The rod-driven a-wave of the dark-adapted mammalian electroretinogram. Prog Retin Eye Res 39:1–22PubMedCrossRef
44.
Zurück zum Zitat Ben-Ari Y (2002) Excitatory actions of gaba during development: the nature of the nurture. Nat Rev Neurosci 3:728–739PubMedCrossRef Ben-Ari Y (2002) Excitatory actions of gaba during development: the nature of the nurture. Nat Rev Neurosci 3:728–739PubMedCrossRef
45.
Zurück zum Zitat Rasmussen AD, Truchot N, Pickersgill N, Thale ZI, Rosolen SG, Botteron C (2015) The effects of taurine on Vigabatrin, high light intensity and mydriasis induced retinal toxicity in the pigmented rat. Exp Toxicol Pathol 67:13–20PubMedCrossRef Rasmussen AD, Truchot N, Pickersgill N, Thale ZI, Rosolen SG, Botteron C (2015) The effects of taurine on Vigabatrin, high light intensity and mydriasis induced retinal toxicity in the pigmented rat. Exp Toxicol Pathol 67:13–20PubMedCrossRef
46.
Zurück zum Zitat McCoy B, Wright T, Weiss S, Go C, Westall CA (2011) Electroretinogram changes in a pediatric population with epilepsy: is vigabatrin acting alone? J Child Neurol 26:729–733PubMedCrossRef McCoy B, Wright T, Weiss S, Go C, Westall CA (2011) Electroretinogram changes in a pediatric population with epilepsy: is vigabatrin acting alone? J Child Neurol 26:729–733PubMedCrossRef
Metadaten
Titel
Vigabatrin can enhance electroretinographic responses in pigmented and albino rats
verfasst von
James D. Akula
Emily R. Noonan
Alessia Di Nardo
Tara L. Favazza
Nan Zhang
Mustafa Sahin
Ronald M. Hansen
Anne B. Fulton
Publikationsdatum
01.08.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Documenta Ophthalmologica / Ausgabe 1/2015
Print ISSN: 0012-4486
Elektronische ISSN: 1573-2622
DOI
https://doi.org/10.1007/s10633-015-9491-0

Weitere Artikel der Ausgabe 1/2015

Documenta Ophthalmologica 1/2015 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.